196 related articles for article (PubMed ID: 1472923)
21. Chronic lymphocytic leukaemia: prognostic factors and natural history.
Montserrat E; Rozman C
Baillieres Clin Haematol; 1993 Dec; 6(4):849-66. PubMed ID: 8038493
[TBL] [Abstract][Full Text] [Related]
22. [Splenectomy for hematologic disease in patients over 70 years of age. Apropos of 38 cases].
Letoquart JP; La Gamma A; Kunin N; Chaperon J
J Chir (Paris); 1995; 132(6-7):295-8. PubMed ID: 7499451
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic large cell lymphoma of the spleen.
Nai GA; Cabello-Inchausti B; Suster S
Pathol Res Pract; 1998; 194(7):517-22. PubMed ID: 9728368
[TBL] [Abstract][Full Text] [Related]
25. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia.
Demir C; Kara E; Ekinci Ö; Ebinç S
Med Sci Monit; 2017 May; 23():2137-2142. PubMed ID: 28473690
[TBL] [Abstract][Full Text] [Related]
27. Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
Magee MJ; McKenzie S; Filippa DA; Arlin ZA; Gee TS; Clarkson BD
Cancer; 1985 Dec; 56(11):2557-62. PubMed ID: 4052933
[TBL] [Abstract][Full Text] [Related]
28. Malignant lymphoma diagnosed at splenectomy and idiopathic splenomegaly. A clinicopathologic comparison.
Long JC; Aisenberg AC
Cancer; 1974 Apr; 33(4):1054-61. PubMed ID: 4819212
[No Abstract] [Full Text] [Related]
29. Splenectomy in advanced chronic lymphocytic leukaemia.
Gallhofer G; Melo JV; Spencer J; Catovsky D
Acta Haematol; 1987; 77(2):78-82. PubMed ID: 3111144
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
31. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
32. [Chronic lymphocytic leukemia: when to start a specific treatment?].
Blaser S; Stirnemann J; Nagy M
Rev Med Suisse; 2013 Oct; 9(402):1870, 1872-4. PubMed ID: 24298709
[TBL] [Abstract][Full Text] [Related]
33. Hairy cell leukaemia. Clinical features and effect of splenectomy.
Jansen J; Hermans J; Remme J; den Ottolander GJ; Cardozo PL
Scand J Haematol; 1978 Jul; 21(1):60-71. PubMed ID: 694419
[TBL] [Abstract][Full Text] [Related]
34. Splenectomy for massive splenomegaly: long-term results and risks for mortality.
Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH
Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL.
Br J Haematol; 1981 Jul; 48(3):365-7. PubMed ID: 7259986
[No Abstract] [Full Text] [Related]
36. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience.
Bouvet M; Babiera GV; Termuhlen PM; Hester JP; Kantarjian HM; Pollock RE
Surgery; 1997 Jul; 122(1):20-5. PubMed ID: 9225910
[TBL] [Abstract][Full Text] [Related]
37. Splenectomy for myelofibrosis.
Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
[TBL] [Abstract][Full Text] [Related]
38. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.
Hollak CE; Belmatoug N; Cole JA; Vom Dahl S; Deegan PB; Goldblatt J; Rosenbloom B; van Dussen L; Tylki-Szymańska A; Weinreb NJ; Zimran A; Cappellini MD
Br J Haematol; 2012 Aug; 158(4):528-38. PubMed ID: 22640238
[TBL] [Abstract][Full Text] [Related]
40. Subtotal splenectomy for the treatment of chronic lymphocytic leukemia.
Petroianu A
Ann Hematol; 2003 Nov; 82(11):708-9. PubMed ID: 12904901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
